Invasive endometrial adenocarcinoma and missed abortion: A case report.

Autor:	Gaulin NB; Department of Obstetrics & Gynecology, West Penn Hospital/Allegheny Health Network, United States., Harinath L; Department of Pathology, West Penn Hospital/Allegheny Health Network, United States., Liang S; Department of Pathology, West Penn Hospital/Allegheny Health Network, United States., Krivak TC; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, West Penn Hospital/Allegheny Health Network, United States., Miller EM; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, West Penn Hospital/Allegheny Health Network, United States.
Jazyk:	angličtina
Zdroj:	Gynecologic oncology reports [Gynecol Oncol Rep] 2019 Dec 21; Vol. 31, pp. 100531. Date of Electronic Publication: 2019 Dec 21 (Print Publication: 2020).
DOI:	10.1016/j.gore.2019.100531
Abstrakt:	Background: Endometrial cancer is the most common gynecologic cancer in the United States; however, reports of endometrial cancer diagnosed in the setting of intrauterine gestation are rare. Case: We describe the case of a clinical stage IA grade 1 endometrioid endometrial adenocarcinoma diagnosed at the time of D&C performed for missed abortion in a gravida 1 para 0 female with no identifiable risk factors. Fertility-sparing treatment, with combined oral megestrol acetate and levonorgestrel intrauterine system, was used to manage this incidentally-diagnosed carcinoma with endometrial sampling every 3 months. Competing Interests: The authors have no personal or financial affiliations to disclose. (© 2019 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu